Patent · US Expired

8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions

US7407955B2 · kind B2 · utility

120Cited by
29References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 12, 2003
Grant dateAug 5, 2008
Priority date
Expiry dateJan 26, 2024

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to substituted xanthines of general formulawherein R1 to R3 are defined as in claims 1 to 16, the tautomers, the stereoisomers, the mixtures, the prodrugs thereof and the salts thereof which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.